These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2000095)

  • 21. Weak genotoxicity of acrylamide on premeiotic and somatic cells of the mouse.
    Russo A; Gabbani G; Simoncini B
    Mutat Res; 1994 Sep; 309(2):263-72. PubMed ID: 7520984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency of dominant cataract and recessive specific-locus mutations in mice derived from 80 or 160 mg ethylnitrosourea per kg body weight treated spermatogonia.
    Favor J
    Mutat Res; 1986 Aug; 162(1):69-80. PubMed ID: 3724777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of dominant lethal mutations by combined X-ray-acrylamide treatment in male mice.
    Dobrzyńska M; Lenarczyk M; Gajewski AK
    Mutat Res; 1990 Oct; 232(2):209-15. PubMed ID: 2215530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of dose rate on the frequency of specific-locus mutations induced in mouse spermatogonia is restricted to larger lesions; a retrospective analysis of historical data.
    Russell LB; Hunsicker PR
    Radiat Res; 2012 May; 177(5):555-64. PubMed ID: 22397578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acrylamide exposure induces a delayed unscheduled DNA synthesis in germ cells of male mice that is correlated with the temporal pattern of adduct formation in testis DNA.
    Sega GA; Generoso EE; Brimer PA
    Environ Mol Mutagen; 1990; 16(3):137-42. PubMed ID: 2209570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of chromosomal aberrations in mouse zygotes by acrylamide treatment of male germ cells and their correlation with dominant lethality and heritable translocations.
    Marchetti F; Lowe X; Bishop J; Wyrobek AJ
    Environ Mol Mutagen; 1997; 30(4):410-7. PubMed ID: 9435882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk.
    Dearfield KL; Douglas GR; Ehling UH; Moore MM; Sega GA; Brusick DJ
    Mutat Res; 1995 Aug; 330(1-2):71-99. PubMed ID: 7623872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of specific-locus and dominant-lethal mutations by cyclophosphamide and combined cyclophosphamide-radiation treatment in male mice.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1988 May; 199(1):21-30. PubMed ID: 3362160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleomycin, unlike other male-mouse mutagens, is most effective in spermatogonia, inducing primarily deletions.
    Russell LB; Hunsicker PR; Kerley MK; Johnson DK; Shelby MD
    Mutat Res; 2000 Aug; 469(1):95-105. PubMed ID: 10946246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic, cytogenetic, and molecular analyses of mutations induced by melphalan demonstrate high frequencies of heritable deletions and other rearrangements from exposure of postspermatogonial stages of the mouse.
    Russell LB; Hunsicker PR; Cacheiro NL; Rinchik EM
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6182-6. PubMed ID: 1352884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorambucil and bleomycin induce mutations in the specific-locus test in female mice.
    Russell LB; Hunsicker PR; Shelby MD
    Mutat Res; 1996 Oct; 358(1):25-35. PubMed ID: 8921974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of specific locus mutations in mouse spermatogonial stem cells by combined chemical X-ray treatments.
    Cattanach BM; Peters J; Rasberry C
    Mutat Res; 1989 May; 212(1):91-101. PubMed ID: 2725545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of specific-locus and dominant lethal mutations in male mice by ifosfamide (Holoxan).
    Ehling UH; Favor J; Neuhäuser-Klaus A; Adler ID
    Genet Res; 1998 Dec; 72(3):177-83. PubMed ID: 10036972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procarbazine-induced specific-locus mutations in male mice.
    Ehling UH; Neuhäuser A
    Mutat Res; 1979 Feb; 59(2):245-56. PubMed ID: 440322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse specific-locus test for the induction of heritable gene mutations by dibromochloropropane (DBCP).
    Russell LB; Hunsicker PR; Cacheiro NL
    Mutat Res; 1986 Jun; 170(3):161-6. PubMed ID: 3713725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heritable translocations induced by dermal exposure of male mice to acrylamide.
    Adler ID; Gonda H; Hrabé de Angelis M; Jentsch I; Otten IS; Speicher MR
    Cytogenet Genome Res; 2004; 104(1-4):271-6. PubMed ID: 15162050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mouse specific-locus test with agents other than radiations: interpretation of data and recommendations for future work.
    Russell LB; Selby PB; von Halle E; Sheridan W; Valcovic L
    Mutat Res; 1981 May; 86(3):329-54. PubMed ID: 7029264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of specific-locus and dominant lethal mutations in male mice by busulfan.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1991 Aug; 249(2):285-92. PubMed ID: 2072971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the dominant lethal effects of acrylonitrile and acrylamide in male Fischer 344 rats.
    Working PK; Bentley KS; Hurtt ME; Mohr KL
    Mutagenesis; 1987 May; 2(3):215-20. PubMed ID: 3325746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific-locus mutation rates in the mouse following inhalation of ethylene oxide, and application of the results to estimation of human genetic risk.
    Russell LB; Cumming RB; Hunsicker PR
    Mutat Res; 1984 Dec; 129(3):381-8. PubMed ID: 6513965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.